ID   U-1690
AC   CVCL_D055
SY   U1690
DR   cancercelllines; CVCL_D055
DR   IARC_TP53; 18696
DR   Wikidata; Q54973515
RX   PubMed=2983887;
RX   PubMed=2990154;
RX   PubMed=12820372;
CC   Doubling time: 5-8 days (PubMed=2990154).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Asp259Val (c.776A>T); ClinVar=VCV000485034; Zygosity=Unspecified (PubMed=12820372).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 13
//
RX   PubMed=2983887;
RA   Saksela K.M., Bergh J., Lehto V.-P., Nilsson K., Alitalo K.;
RT   "Amplification of the c-myc oncogene in a subpopulation of human small
RT   cell lung cancer.";
RL   Cancer Res. 45:1823-1827(1985).
//
RX   PubMed=2990154; DOI=10.1111/j.1699-0463.1985.tb03932.x;
RA   Bergh J., Nilsson K., Ekman R., Giovanella B.C.;
RT   "Establishment and characterization of cell lines from human small
RT   cell and large cell carcinomas of the lung.";
RL   Acta Pathol. Microbiol. Immunol. Scand. A. 93:133-147(1985).
//
RX   PubMed=12820372;
RA   Bergqvist M., Brattstrom D., Gullbo J., Hesselius P., Brodin O.,
RA   Wagenius G.;
RT   "p53 status and its in vitro relationship to radiosensitivity and
RT   chemosensitivity in lung cancer.";
RL   Anticancer Res. 23:1207-1212(2003).
//